Scotts Miracle-Gro
What analysts say:
- Buy, sell, or hold?: Analysts think investors should stand pat on Scotts Miracle-Gro, with eight out of 11 analysts rating it hold.
- Revenue forecasts: On average, analysts predict $205.6 million in revenue this quarter. That would represent a decline of 10.7% from the year-ago quarter.
- Wall Street earnings expectations: The average analyst estimate is a loss of $1.22 per share. Estimates range from a loss of $1.25 to a loss of $1.20.
What our community says:
CAPS All-Stars are in strong support of the stock, with 90.8% awarding it an outperform rating. The greater community concurs with the All-Stars, as 86.8% give it a rating of outperform. Fools are impressed with Scotts Miracle-Gro and haven't been shy with their opinions lately, logging 131 posts in the past 30 days. Despite the majority sentiment in favor of Scotts Miracle-Gro, the stock has a middling CAPS rating of three out of five stars.
Management:
Revenue has fallen in the past two quarters. The company's gross margin shrank by 7.9 percentage points in the last quarter. Revenue fell 12.3% while cost of sales fell 2.5% to $326.1 million from a year earlier.
Quarter | Q4 | Q3 | Q2 | Q1 |
Gross Margin | 21.8% | 37.8% | 41% | 21.3% |
Operating Margin | (23.1%) | 18.2% | 21.7% | (41.1%) |
Net Margin | (12.8%) | 10.5% | 15.7% | (29.5%) |
For all our Scotts Miracle-Gro-specific analysis, including earnings and beyond, add Scotts Miracle-Gro to My Watchlist.
Motley Fool newsletter services have recommended buying shares of Scotts Miracle-Gro. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Earnings estimates provided by Zacks.